Lincoln Park Bancorp (LPBC) 6.4300 $LPBC
See Chicago's Premier Vintage Home Restorations On May 18
PR Newswire - Thu May 01, 10:00AM CDT
Chicago's late 19th century architectural renaissance can be experienced first-hand on Sunday, May 18 during the 26th Annual City Style House Tour. Six East Lincoln Park homes, some of the finest examples of historic preservation and re-imagined interior spaces, will be open for touring from 1 to 5 p.m.
Experience the Difference at Lincoln Park Manor; Named Best Nursing Home
PRWeb - Thu Apr 24, 3:23PM CDT
U.S. News awarded the "Best Nursing Home" designation to those facilities that earned a five-star rating from the Centers for Medicare & Medicaid Services; this is one of the top indicators of excellence in health inspections, clinical staffing and quality of care.
RXi Pharmaceuticals expects to sell up to USD20m under the purchase agreement with LPC
M2 - Wed Apr 23, 3:07AM CDT
Biotechnology company RXi Pharmaceuticals (RXII) stated on Tuesday that it will sell up to an aggregate of USD20m shares of its common stock over a 30-month period to Lincoln Park Capital Fund (LPC) under a purchase agreement.
RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital
PR Newswire - Tue Apr 22, 2:29PM CDT
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, announced today that it has entered into a purchase agreement (the "Purchase Agreement"
with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor, whereby LPC is committed to purchase up to an aggregate of up to $20 million shares of RXi common stock over a 30-month term. The funds, in part, will serve to advance research and development activities for the Company's ophthalmological pre-clinical drug pipeline.
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund
ACCESSWIRE - Tue Apr 15, 9:01AM CDT
Elite Pharmaceuticals Inc. (OTCBB: ELTP) announced Apr. 14 that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund LLC ("LPC", a Chicago-based institutional investor for up to $40 million.
Elite Pharmaceuticals, Inc. Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Apr 14, 6:30AM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company" (OTCBB:ELTP) announced today that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor for up to $40 Million. Proceeds from the transaction will be used to develop the Company's pipeline of products, including the abuse resistant opioids, and for general corporate purposes.
Acer Announces 10 Finalists in its Extreme Technology Makeover Program to Further 21st Century Learning
PRWeb - Fri Apr 11, 7:05AM CDT
Acer America announced the 10 finalists in its Acer Extreme Classroom Technology Makeover program, which provides K-12 schools in the U.S. the opportunity to transform a classroom with immersive tablet technology. Tablets enhance the learning experience by making it more hands-on, interactive and engaging as well as encouraging collaboration to explore more.
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones"
ACCESSWIRE - Mon Mar 10, 12:46PM CDT
New York, NY / ACCESSWIRE / March 10, 2014 / Amarantus BioScience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman's Blog, written by the Company's CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Mar 10, 5:00AM CDT
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M.
Experience the Difference at Lincoln Park Manor; Recognized for Deficiency-Free Health Survey
PRWeb - Sat Mar 08, 11:45AM CST
Russ Holtz, Executive Director of Lincoln Mark Manor, is proud of the 2014 survey results and is honored with the overall 5-Star rating from Medicare. Holtz states, "We have maintained this outstanding accomplishment for the second consecutive year. We understand the importance of having an amazing, caring team of staff members who continue to play a key role towards this distinction year after year."
PourMyBeer™ Revolutionizes Beer Service in Chicago with Introduction of Self-Serve System
PRWeb - Fri Mar 07, 5:05AM CST
Craft beer is at an all-time high and customer demand for beer means the need to serve them more quickly, efficiently and responsibly is greater than ever. Enter the PourMyBeer™ system. It conveniently allows customers to purchase and pour their own beer, with staff interaction and oversight of course. It also allows customers to pay only for what they drink, instead of a packaged or predetermined amount. By reserving a PourMyBeer™ table, customers can guarantee favorite draft beers will be on tap for the night.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company" (TSX:ONC; NASDAQ:ONCY) announced today that it has entered into a share purchase agreement (the "Purchase Agreement" with Lincoln Park Capital Fund, LLC ("LPC" that will provide an initial investment in Oncolytics of US$1.0 million and make available additional periodic investments of up to US$25.0 million over a 30-month term (the "Financing".
Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
ACCESSWIRE - Tue Feb 25, 3:48AM CST
Verizon Communications Inc. (NYSE: VZ) - For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
Marketwire - Mon Feb 24, 8:04AM CST
Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials. Notice we said restricted shares, that's right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex. But, is this investment really a risk? It appears the Chicago-based firm knows exactly what the future could hold for Nuvilex, and they're comfortable with paying a premium price to become a long-term investor right along with many others who believe in the small biotechnology firm.
HPEV, Inc. Enters Into $10 Million Stock Purchase Agreement With Lincoln Park Capital Fund, LLC
Marketwire - Mon Feb 24, 5:21AM CST
HPEV, Inc. (OTCQB: WARM), an innovator in energy efficiency and heat dispersion technologies, announced today that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor, whereby LPC committed to invest, at the HPEV's sole option, up to $10 million of equity capital pursuant to the purchase agreement. Drexel Hamilton LLC acted as the exclusive placement agent on behalf of the Company for the transaction.
Nuvilex Announces $27 Million Funding Commitment With Institutional Investor to Advance Late Phase Clinical Trials
GlobeNewswire - Thu Feb 20, 8:00AM CST
Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (Lincoln Park), a Chicago-based institutional investor. Lincoln Park initially purchased 8 million shares of Nuvilex's common stock at $0.25 per share for $2 million and has committed to invest, at the sole option of Nuvilex, up to an additional $25 million of equity capital over the term of the purchase agreement. The proceeds from this investment will be used for Nuvilex's late-stage clinical trials in advanced inoperable pancreatic cancer, for research into the use of constituents of marijuana in the emerging medical marijuana arena and for general operating purposes.
Artisanal Grocery Online Store Artizone.com Partners With WeDeliver For Delivery Efficacy
PR Newswire - Tue Feb 11, 4:00PM CST
Artizone.com, Chicagoland's only online and year-round marketplace for fresh, small-batch, high-quality foods is partnering with on-demand local delivery service WeDeliver to help increase delivery and product availability from some of Artizone's popular artisan partners.
KonaRed Corp Analyst Report issued by BrokerBank Securities, Inc.
PR Newswire - Tue Feb 11, 6:00AM CST
KonaRed Corp (OTCQB: KRED) brings the health and wellness properties of the coffee fruit (the shell that surrounds the coffee bean) to the market. KonaRed has developed an innovative, process that produces antioxidant-packed extracts and powders from the coffee fruit which are used in its antioxidant juices, organic green teas, and on-the-go packs, as well as ingredients which can be added to food, beverages, and nutritional products.
Plandai Biotechnology, Inc. Completes $15.3 Million Funding Commitment With Institutional Investor
Marketwire - Mon Feb 10, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor, whereby Lincoln Park committed to invest, at the Company's sole option, up to $15.3 million of equity capital over the term of the purchase agreement including an initial investment of $300,000.
See Chicago's Premier Vintage Home Restorations On May 18
PR Newswire - Thu May 01, 10:00AM CDT
Chicago's late 19th century architectural renaissance can be experienced first-hand on Sunday, May 18 during the 26th Annual City Style House Tour. Six East Lincoln Park homes, some of the finest examples of historic preservation and re-imagined interior spaces, will be open for touring from 1 to 5 p.m.
Experience the Difference at Lincoln Park Manor; Named Best Nursing Home
PRWeb - Thu Apr 24, 3:23PM CDT
U.S. News awarded the "Best Nursing Home" designation to those facilities that earned a five-star rating from the Centers for Medicare & Medicaid Services; this is one of the top indicators of excellence in health inspections, clinical staffing and quality of care.
RXi Pharmaceuticals expects to sell up to USD20m under the purchase agreement with LPC
M2 - Wed Apr 23, 3:07AM CDT
Biotechnology company RXi Pharmaceuticals (RXII) stated on Tuesday that it will sell up to an aggregate of USD20m shares of its common stock over a 30-month period to Lincoln Park Capital Fund (LPC) under a purchase agreement.
RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital
PR Newswire - Tue Apr 22, 2:29PM CDT
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, announced today that it has entered into a purchase agreement (the "Purchase Agreement"
with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor, whereby LPC is committed to purchase up to an aggregate of up to $20 million shares of RXi common stock over a 30-month term. The funds, in part, will serve to advance research and development activities for the Company's ophthalmological pre-clinical drug pipeline. Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund
ACCESSWIRE - Tue Apr 15, 9:01AM CDT
Elite Pharmaceuticals Inc. (OTCBB: ELTP) announced Apr. 14 that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund LLC ("LPC"
, a Chicago-based institutional investor for up to $40 million. Elite Pharmaceuticals, Inc. Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Apr 14, 6:30AM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"
(OTCBB:ELTP) announced today that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor for up to $40 Million. Proceeds from the transaction will be used to develop the Company's pipeline of products, including the abuse resistant opioids, and for general corporate purposes. Acer Announces 10 Finalists in its Extreme Technology Makeover Program to Further 21st Century Learning
PRWeb - Fri Apr 11, 7:05AM CDT
Acer America announced the 10 finalists in its Acer Extreme Classroom Technology Makeover program, which provides K-12 schools in the U.S. the opportunity to transform a classroom with immersive tablet technology. Tablets enhance the learning experience by making it more hands-on, interactive and engaging as well as encouraging collaboration to explore more.
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones"
ACCESSWIRE - Mon Mar 10, 12:46PM CDT
New York, NY / ACCESSWIRE / March 10, 2014 / Amarantus BioScience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman's Blog, written by the Company's CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Mar 10, 5:00AM CDT
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M. Experience the Difference at Lincoln Park Manor; Recognized for Deficiency-Free Health Survey
PRWeb - Sat Mar 08, 11:45AM CST
Russ Holtz, Executive Director of Lincoln Mark Manor, is proud of the 2014 survey results and is honored with the overall 5-Star rating from Medicare. Holtz states, "We have maintained this outstanding accomplishment for the second consecutive year. We understand the importance of having an amazing, caring team of staff members who continue to play a key role towards this distinction year after year."
PourMyBeer™ Revolutionizes Beer Service in Chicago with Introduction of Self-Serve System
PRWeb - Fri Mar 07, 5:05AM CST
Craft beer is at an all-time high and customer demand for beer means the need to serve them more quickly, efficiently and responsibly is greater than ever. Enter the PourMyBeer™ system. It conveniently allows customers to purchase and pour their own beer, with staff interaction and oversight of course. It also allows customers to pay only for what they drink, instead of a packaged or predetermined amount. By reserving a PourMyBeer™ table, customers can guarantee favorite draft beers will be on tap for the night.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company"
(TSX:ONC; NASDAQ:ONCY) announced today that it has entered into a share purchase agreement (the "Purchase Agreement" with Lincoln Park Capital Fund, LLC ("LPC" that will provide an initial investment in Oncolytics of US$1.0 million and make available additional periodic investments of up to US$25.0 million over a 30-month term (the "Financing". Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
ACCESSWIRE - Tue Feb 25, 3:48AM CST
Verizon Communications Inc. (NYSE: VZ) - For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
Marketwire - Mon Feb 24, 8:04AM CST
Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials. Notice we said restricted shares, that's right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex. But, is this investment really a risk? It appears the Chicago-based firm knows exactly what the future could hold for Nuvilex, and they're comfortable with paying a premium price to become a long-term investor right along with many others who believe in the small biotechnology firm.
HPEV, Inc. Enters Into $10 Million Stock Purchase Agreement With Lincoln Park Capital Fund, LLC
Marketwire - Mon Feb 24, 5:21AM CST
HPEV, Inc. (OTCQB: WARM), an innovator in energy efficiency and heat dispersion technologies, announced today that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor, whereby LPC committed to invest, at the HPEV's sole option, up to $10 million of equity capital pursuant to the purchase agreement. Drexel Hamilton LLC acted as the exclusive placement agent on behalf of the Company for the transaction. Nuvilex Announces $27 Million Funding Commitment With Institutional Investor to Advance Late Phase Clinical Trials
GlobeNewswire - Thu Feb 20, 8:00AM CST
Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (Lincoln Park), a Chicago-based institutional investor. Lincoln Park initially purchased 8 million shares of Nuvilex's common stock at $0.25 per share for $2 million and has committed to invest, at the sole option of Nuvilex, up to an additional $25 million of equity capital over the term of the purchase agreement. The proceeds from this investment will be used for Nuvilex's late-stage clinical trials in advanced inoperable pancreatic cancer, for research into the use of constituents of marijuana in the emerging medical marijuana arena and for general operating purposes.
Artisanal Grocery Online Store Artizone.com Partners With WeDeliver For Delivery Efficacy
PR Newswire - Tue Feb 11, 4:00PM CST
Artizone.com, Chicagoland's only online and year-round marketplace for fresh, small-batch, high-quality foods is partnering with on-demand local delivery service WeDeliver to help increase delivery and product availability from some of Artizone's popular artisan partners.
KonaRed Corp Analyst Report issued by BrokerBank Securities, Inc.
PR Newswire - Tue Feb 11, 6:00AM CST
KonaRed Corp (OTCQB: KRED) brings the health and wellness properties of the coffee fruit (the shell that surrounds the coffee bean) to the market. KonaRed has developed an innovative, process that produces antioxidant-packed extracts and powders from the coffee fruit which are used in its antioxidant juices, organic green teas, and on-the-go packs, as well as ingredients which can be added to food, beverages, and nutritional products.
Plandai Biotechnology, Inc. Completes $15.3 Million Funding Commitment With Institutional Investor
Marketwire - Mon Feb 10, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor, whereby Lincoln Park committed to invest, at the Company's sole option, up to $15.3 million of equity capital over the term of the purchase agreement including an initial investment of $300,000.
